Artia Global Partners Lp Top Holdings and 13F Report (2025) About Artia Global Partners LpInvestment ActivityArtia Global Partners Lp has $415.64 million in total holdings as of June 30, 2025.Artia Global Partners Lp owns shares of 35 different stocks, but just 9 companies or ETFs make up 80% of its holdings.Approximately 42.28% of the portfolio was purchased this quarter.About 46.42% of the portfolio was sold this quarter.This quarter, Artia Global Partners Lp has purchased 32 new stocks and bought additional shares in 9 stocks.Artia Global Partners Lp sold shares of 7 stocks and completely divested from 9 stocks this quarter.Largest Holdings Verona Pharma PLC American Depositary Share $96,093,658Insmed $79,778,536argenex $43,166,589Soleno Therapeutics $41,422,843Eli Lilly and Company $23,931,571 Largest New Holdings this Quarter 78464A870 - SPDR S&P Biotech ETF $8,293,000 Holding89532M101 - Trevi Therapeutics $7,175,765 Holding74347W601 - ProShares Ultra Gold $5,822,880 Holding75886F107 - Regeneron Pharmaceuticals $5,602,275 Holding00287Y109 - AbbVie $2,691,490 Holding Largest Purchases this Quarter Insmed 474,473 shares (about $47.75M)Verona Pharma PLC American Depositary Share 477,516 shares (about $45.16M)argenex 67,000 shares (about $36.93M)SPDR S&P Biotech ETF 100,000 shares (about $8.29M)Trevi Therapeutics 1,311,840 shares (about $7.18M) Largest Sales this Quarter Eli Lilly and Company 109,187 shares (about $85.11M)Soleno Therapeutics 240,949 shares (about $20.19M)Protagonist Therapeutics 310,900 shares (about $17.18M)Merus 127,890 shares (about $6.73M)Alnylam Pharmaceuticals 7,630 shares (about $2.49M) Sector Allocation Over TimeMap of 500 Largest Holdings ofArtia Global Partners Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorVRNAVerona Pharma PLC American Depositary Share$96,093,658$45,163,463 ▲88.7%1,016,00423.1%MedicalINSMInsmed$79,778,536$47,750,963 ▲149.1%792,71219.2%MedicalARGXargenex$43,166,589$36,931,740 ▲592.3%78,31110.4%MedicalSLNOSoleno Therapeutics$41,422,843$20,186,707 ▼-32.8%494,42410.0%MedicalLLYEli Lilly and Company$23,931,571$85,114,542 ▼-78.1%30,7005.8%MedicalBSXBoston Scientific$16,670,032$2,738,955 ▲19.7%155,2004.0%MedicalMRUSMerus$15,609,050$6,727,014 ▼-30.1%296,7503.8%MedicalDGXQuest Diagnostics$14,678,825$4,490,750 ▲44.1%81,7173.5%MedicalAZNAstraZeneca$13,329,7500.0%190,7523.2%MedicalXBISPDR S&P Biotech ETF$8,293,000$8,293,000 ▲New Holding100,0002.0%ETFTRVITrevi Therapeutics$7,175,765$7,175,765 ▲New Holding1,311,8401.7%MedicalALNYAlnylam Pharmaceuticals$6,838,107$2,488,067 ▼-26.7%20,9701.6%MedicalUGLProShares Ultra Gold$5,822,880$5,822,880 ▲New Holding168,0001.4%ETFREGNRegeneron Pharmaceuticals$5,602,275$5,602,275 ▲New Holding10,6711.3%MedicalSRRKScholar Rock$4,473,015$1,625,778 ▼-26.7%126,2851.1%MedicalRVMDRevolution Medicines$3,833,1500.0%104,1900.9%MedicalSWTXSpringWorks Therapeutics$3,004,071$469,900 ▲18.5%63,9300.7%MedicalEYPTEyepoint Pharmaceuticals$2,980,1470.0%316,7000.7%MedicalABBVAbbVie$2,691,490$2,691,490 ▲New Holding14,5000.6%MedicalVKTXViking Therapeutics$2,556,694$164,300 ▲6.9%96,4790.6%MedicalASNDAscendis Pharma A/S$2,112,624$828,480 ▲64.5%12,2400.5%MedicalTGTXTG Therapeutics$1,961,9950.0%54,5150.5%MedicalVRTXVertex Pharmaceuticals$1,958,880$1,958,880 ▲New Holding4,4000.5%MedicalRAREUltragenyx Pharmaceutical$1,520,939$1,520,939 ▲New Holding41,8300.4%MedicalUTHRUnited Therapeutics$1,436,7500.0%5,0000.3%MedicalMREOMereo BioPharma Group$1,288,228$146,345 ▲12.8%475,3610.3%MedicalPTGXProtagonist Therapeutics$1,268,502$17,183,446 ▼-93.1%22,9510.3%MedicalXENEXenon Pharmaceuticals$1,252,0000.0%40,0000.3%MedicalBHVNBiohaven$1,128,800$1,128,800 ▲New Holding80,0000.3%MedicalRNAAvidity Biosciences$982,640$982,640 ▲New Holding34,6000.2%MedicalKINIKSA PHARMACEUTICALS INTL$807,964$807,964 ▲New Holding29,2000.2%ORD SHS CL AMLYSMineralys Therapeutics$556,083$556,083 ▲New Holding41,1000.1%MedicalNAMSNewAmsterdam Pharma$494,747$494,747 ▲New Holding27,3190.1%MedicalJANXJanux Therapeutics$462,000$418,110 ▼-47.5%20,0000.1%MedicalTVTXTravere Therapeutics$457,3200.0%30,9000.1%MedicalITCIIntra-Cellular Therapies$0$28,985,330 ▼-100.0%00.0%MedicalACLXArcellx$0$15,027,976 ▼-100.0%00.0%MedicalNUVLNuvalent$0$6,435,635 ▼-100.0%00.0%MedicalRYTMRhythm Pharmaceuticals$0$2,648,500 ▼-100.0%00.0%MedicalVRDNViridian Therapeutics$0$2,156,800 ▼-100.0%00.0%MedicalISRGIntuitive Surgical$0$1,733,445 ▼-100.0%00.0%MedicalNBIXNeurocrine Biosciences$0$1,625,820 ▼-100.0%00.0%MedicalCNTACentessa Pharmaceuticals$0$506,550 ▼-100.0%00.0%MedicalORUKA THERAPEUTICS INC$0$75,719 ▼-100.0%00.0%COMShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access